Astec LifeSciences · NSE: ASTEC · BSE: 533138
Q1 FY19 results · Apr–Jun 2018
Astec LifeSciences reported revenue from operations of ₹65.47 crore and net profit of ₹1.49 crore for Q1 FY19 (Apr–Jun 2018), on a consolidated basis.
| Item | Q1 FY19 | Q1 FY18 | YoY | Q4 FY18 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 65.47 | — | — | — | — |
| Other income | 0.02 | — | — | — | — |
| Total income | 65.49 | — | — | — | — |
| Profit before tax | 2.45 | — | — | — | — |
| Net profit for the period | 1.49 | — | — | — | — |
| EPS, basic (₹) | 0.08 | — | — | — | — |
| Net margin (%) | 2.3 | — | — |
| Item | Q1 FY19 | Q1 FY18 | YoY | Q4 FY18 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 65.47 | — | — | — | — |
| Other income | 0.02 | — | — | — | — |
| Total income | 65.49 | — | — | — | — |
| Profit before tax | 2.43 | — | — | — | — |
| Net profit for the period | 1.48 | — | — | — | — |
| EPS, basic (₹) | 0.08 | — | — | — | — |
| Net margin (%) | 2.3 | — | — |
Consolidated
- Filed with BSE
- 02 Aug 2018, 15:44 IST
- Board meeting
- 01 Aug 2018
- Period
- 01 Apr 2018 to 30 Jun 2018
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 02 Aug 2018, 15:44 IST
- Board meeting
- 01 Aug 2018
- Period
- 01 Apr 2018 to 30 Jun 2018
- Review status
- Unaudited
- Source
- XBRL filing on BSE